In this pan-cancer analysis, the frequency of KDM5C alterations was 2.1% in a cohort of 45614 cancer patients, with esophagogastric cancer, endometrial carcinoma and renal cell carcinoma having the highest levels of KDM5C alterations, which was similar to previous publications (21, 22). Here, KDM5C is linked to cancer.